Trademark Overview
On Monday, May 23, 2022, a trademark application was filed for EMRUSOLMIN with the United States Patent and Trademark Office. The USPTO has given the EMRUSOLMIN trademark a serial number of 97423939. The federal status of this trademark filing is ABANDONED - EXPRESS as of Thursday, June 30, 2022. This trademark is owned by MODAG GmbH. The EMRUSOLMIN trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Medicines for human purposes; Medicines for veterinary purposes; Pharmaceuticals and natural remedies; Medicines for the treatment of Alzheimer's disease; Medicines for the treatment of neurodegenerative diseases; Medicines for the treatment of cardiovascular and cerebrovascular diseases; Chemico-pharmaceutical preparations; Chemical reagents for medical or veterinary purposes; Diagnostic preparations for medical or veterinary purposes; Diagnostic preparations and materials; Diagnostic biomarker reagents for medical purposes; Diagnostic reagents for medical use; Dragees; Injectable pharmaceuticals; Medicinal preparations and substances; Antiparkinson agents; Pharmaceutical drugs; Pharmaceuticals; Pharmaceutical preparations for human use; Pharmaceutical preparations for the treatment of Parkinson's disease; Pharmaceutical preparations for the treatment of Alzeimer's disease; Pharmaceutical preparations for the treatment of neurodegenerative diseases; Pharmaceutical preparations for the...
Medication counseling; Providing information to patients in the field of administering medications; Provision of information relating to pharmaceutical products; Provision of information relating to the treatment of degenerative diseases; Provision of information relating to medical services; Provision of pharmaceutical information; Advisory services relating to the treatment of degenerative diseases; Consultancy and information services relating to pharmaceutical products; Consultancy and information services provided via the Internet relating to pharmaceutical products; Consultancy and information services relating to medical products; Advisory services relating to medicines; Medical services; Medical services for treating Alzheimer's disease; Pharmaceutical services; Preparation and dispensing of medications
Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Consultancy relating to pharmaceutical research and development; Biological research, clinical research and medical research; Medical research laboratory services; Testing of pharmaceuticals; Analysis of human serum for medical research; Analysis of human tissues for medical research; Development of pharmaceutical preparations and medicines; Pharmaceutical products development; Research and development of vaccines and medicines; Providing scientific information in the field of medical disorders and their treatment; Research in the field of pharmacogenetics; Research on the subject of pharmaceuticals; Research and development in the pharmaceutical and biotechnology fields; Clinical research; Laboratory research services relating to pharmaceuticals; Medical research; Medical and pharmacological research services; Pharmaceutical drug development services; Pharmaceutical research serv...
